Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term en [Enzymology]. Found 8 abstracts

Meropol NJ, Gold PJ, Diasio RB, Andria M, Dhami M, Godfrey T, Kovatich AJ, Lund KA, Mitchell E, Schwarting R. Thymidine phosphorylase expression is associated with response to capecitabine plus irinotecan in patients with metastatic colorectal cancer.[see comment]. Journal of Clinical Oncology. 2006 Sep;24(25):4069-77.
Cheng JD, Valianou M, Canutescu AA, Jaffe EK, Lee HO, Wang H, Lai JH, Bachovchin WW, Weiner LM. Abrogation of fibroblast activation protein enzymatic activity attenuates tumor growth. Molecular Cancer Therapeutics. 2005 Mar;4(3):351-60.
Lopez de Cicco R, Bassi DE, Zucker S, Seidah NG, Klein-Szanto AJ. Human carcinoma cell growth and invasiveness is impaired by the propeptide of the ubiquitous proprotein convertase furin. Cancer Research. 2005 May 15;65(10):4162-71.
Badawi AF, Eldeen MB, Liu Y, Ross EA, Badr MZ. Inhibition of rat mammary gland carcinogenesis by simultaneous targeting of cyclooxygenase-2 and peroxisome proliferator-activated receptor gamma. Cancer Research. 2004 Feb;64(3):1181-9.
Badawi AF, Liu Y, Eldeen MB, Morrow W, Razak ZR, Maradeo M, Badr MZ. Age-associated changes in the expression pattern of cyclooxygenase-2 and related apoptotic markers in the cancer susceptible region of rat prostate. Carcinogenesis. 2004 Sep;25(9):1681-8.
Subhi AL, Tang B, Balsara BR, Altomare DA, Testa JR, Cooper HS, Hoffman JP, Meropol NJ, Kruger WD. Loss of methylthioadenosine phosphorylase and elevated ornithine decarboxylase is common in pancreatic cancer. Clinical Cancer Research. 2004 Nov;10(21):7290-6.
Taganov KD, Cuesta I, Daniel R, Cirillo LA, Katz RA, Zaret KS, Skalka AM. Integrase-specific enhancement and suppression of retroviral DNA integration by compacted chromatin structure in vitro. Journal of Virology. 2004 Jun;78(11):5848-55.
Bao R, Connolly DC, Murphy M, Green J, Weinstein JK, Pisarcik DA, Hamilton TC. Activation of cancer-specific gene expression by the survivin promoter. Journal of the National Cancer Institute. 2002 Apr 03;94(7):522-8.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term en [Enzymology]

en [Enzymology] me [Metabolism] pa [Pathology] ph [Physiology] Non-US Gov't Research Support ge [Genetics] Biological Tumor Markers ch [Chemistry] Biological) 0 (Tumor Markers Tumor Cell Line bi [Biosynthesis] Apoptosis Transfection Female US Gov't Support-PHS pd [Pharmacology] Enzymologic Gene Expression Regulation 0 (Isoenzymes) ad [Administration & Dosage] aa [Analogs & Derivatives] Male Rats Transcription Factors Dinoprostone Mice Prostaglandin-Endoperoxide Synthase 363-24-6 (Dinoprostone) EC 1-14-99-1 (Prostaglandin-Endoperoxide Synthase) Immunohistochemistry Western Blotting Isoenzymes Binding Sites Neoplastic Gene Expression Regulation 9007-49-2 (dna) Neoplasm) 0 (Antigens Purine-Nucleoside Phosphorylase dt [Drug Therapy] Prostaglandin D2 Neoplasms Inbred C57BL Mice Head and Neck Neoplasms Reporter Genes ci [Chemically Induced] Sulfonamides 0 (Transcription Factors) Thymidine Phosphorylase 0 (Microtubule-Associated Proteins) Colorectal Neoplasms US Gov't Support-Non-PHS Inbred ICR Mice Fluorouracil Cultured Tumor Cells 7689-03-4 (Camptothecin) Predictive Value of Tests Antineoplastic Agents 0 (Bax protein) 154361-50-9 (capecitabine) Ovarian Neoplasms EC 2-7-1-37 (Protein Kinase C) Alanine EC 2-4-2-4 (Thymidine Phosphorylase) Neoplasm Transplantation 61-90-5 (Leucine) EC 3-4-21-75 (Furin) 0 (Proto-Oncogene Proteins c-bcl-2) de [Drug Effects] Protein p16 pc [Prevention & Control] DNA 56-45-1 (Serine) Antineoplastic Combined Chemotherapy Protocols SCID Mice Furin tu [Therapeutic Use] Thymidylate Synthase Proto-Oncogene Proteins vi [Virology] EC 3-1-3-1 (Alkaline Phosphatase) Non-Histone) 0 (Chromosomal Proteins Flow Cytometry Fluorescence In Situ Hybridization 56-41-7 (Alanine) Cell Cycle Effects] Human Chromosomes-Pair 9 Serine Complementary DNA Neuroendocrine Tumors Biological Markers Anticarcinogenic Agents Cell Growth Processes Non-US Gov't Support Nuclear Proteins Protein Precursors Cytoplasmic and Nuclear) 0 (Receptors 0 (Carcinogens) 0 (Biological Markers) Retroviridae 0 (fibroblast-activating factor) Nucleosomes ag [Agonists] Fluorenes Squamous Cell Carcinoma 51-21-8 (Fluorouracil) Virus Integration Neoplasm Antigens ae [Adverse EC 2-1-1-45 (Thymidylate Synthase) Adult Non-Histone Chromosomal Proteins 0 (Proto-Oncogene Proteins) Protein Kinase C 169590-42-5 (celecoxib) Cysteine Proteinase Inhibitors 0 (Cyclooxygenase Inhibitors) Survival Analysis human) 0 (survivin protein Pathologic Neovascularization EC 3-4-14 (Dipeptidyl Peptidases) bs [Blood Supply] EC 1-14-99 (cyclooxygenase 2) 0 (Peptide Fragments) Drug Synergism Middle Aged 684-93-5 (Methylnitrosourea) Camptothecin Integrases 80 and over Aged Fibroblasts 0 (Protein p16) Molecular Models Peptide Fragments Inbred F344 Rats EC 2-7-1 (protein kinase C alpha) Cell Line Catalytic Domain Aging Serine Endopeptidases 0 (Protein Precursors) EC 2-4-2-28 (5'-methylthioadenosine phosphorylase) Carcinogens Kinetics 35661-60-0 (N-(fluorenyl-9-methoxycarbonyl)leucine) Ornithine Decarboxylase Experimental Mammary Neoplasms Proportional Hazards Models 0 (Fluorenes) Pancreatic Neoplasms ai [Antagonists & Inhibitors]
Last updated on Wednesday, March 04, 2020